Identifying the Factors Underlying Discontinuation of Triptans-Reference-Cited by-同舟云学术

Identifying the Factors Underlying Discontinuation of Triptans

Published:2013-09-03 Issue:2 Volume:54 Page:278-289
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache: The Journal of Head and Face Pain

Author:

Wells Rebecca E.¹,Markowitz Shira Y.²,Baron Eric P.³,Hentz Joseph G.⁴,Kalidas Kavita⁵,Mathew Paul G.⁶,Halker Rashmi⁴,Dodick David W.⁴,Schwedt Todd J.⁴

Affiliation:

1. Wake Forest School of Medicine; Winston-Salem NC USA

2. Laniado Hospital; Netanya Israel

3. Center for Headache and Pain; Cleveland Clinic Neurological Institute; Cleveland OH USA

4. Mayo Clinic Arizona; Phoenix AZ USA

5. Neurology; University of South Florida; Tampa FL USA

6. Brigham and Women's Hospital; Harvard Medical School; John R. Graham Headache Center; Boston MA USA

Funder

American Headache Society

Investigator Initiated Studies Program of Merck & Co., Inc.

Caridian BCT

Robert Wood Johnson Foundation

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/head.12198/fullpdf

Reference12 articles.

1. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the quality standards subcommittee of the American Academy of Neurology;Silberstein;Neurology,2000

2. Migraine prevalence and treatment patterns: The global migraine and zolmitriptan evaluation survey;MacGregor;Headache,2003

3. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: Results from the American Migraine Prevalence and Prevention (AMPP) study;Holland;J Neurol Sci,2013

4. Migraine diagnosis and treatment: Results from the American migraine study II;Lipton;Headache,2001

5. Influence of disease features on adherence to prophylactic migraine medication;Linde;Acta Neurol Scand,2008

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 3‐year follow‐up study of outcomes associated with patterns of traditional acute and preventive migraine treatment: An administrative claims‐based cohort study in the United States;Headache: The Journal of Head and Face Pain;2024-06-19

2. Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UK;Journal of Medical Economics;2024-04-27

3. Migraine treatment: quo vadis? Real-world data study (2015–2022) in Spain;BMC Neurology;2024-04-02

4. Medication “underuse” headache;Cephalalgia;2024-04

5. Safety and efficacy of ubrogepant for the acute treatment of perimenstrual migraine attacks: A post hoc analysis;Headache: The Journal of Head and Face Pain;2023-09